Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

GLP-1RAs were associated with lower risk for major adverse cardiovascular and cerebrovascular events in MGUS with type 2 diabetes.

A study has found that greater cancer risk is associated with worse cardiovascular health metrics and cardiovascular disease risk scores.

For children with type 1 diabetes (T1D), glycated hemoglobin (HbA1c) levels are associated with accessibility of modern diabetes technologies and insulin.

Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control.

There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

There is no association between atrial fibrillation and increased poststroke dementia risk in patients with first-ever acute ischemic stroke.

Topline results were announced from a phase 3 trial evaluating the safety, tolerability, and immunogenicity of Pfizer-BioNTech’s LP.8.1-adapted COVID-19 vaccine.

For patients with acute myocardial infarction (MI), beta-blockers are not beneficial in those without reduced left ventricular ejection fraction (LVEF).

Semaglutide was associated with a significantly greater reduction in MACE risk vs tirzepatide in patients with overweight/obesity and CVD.

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.